SciTransfer
Organization

JOHN INNES CENTRE

Premier UK plant science institute specializing in crop genetics, genome editing, epigenetics, and natural product discovery for agriculture and biomanufacturing.

Research institutefoodUK
H2020 projects
38
As coordinator
22
Total EC funding
€24.5M
Unique partners
124
What they do

Their core work

The John Innes Centre is one of Europe's leading independent plant and microbial science research institutes, based in Norwich, UK. Their core work spans plant genetics, epigenetics, crop improvement, and natural product chemistry — translating fundamental discoveries about how plants grow, reproduce, and defend themselves into practical advances for agriculture and biomanufacturing. They are particularly strong in cereal crop science (wheat, barley), genome editing technologies, and understanding how RNA and DNA methylation regulate plant development. Their research directly supports breeding better crop varieties and developing plants as production platforms for pharmaceuticals and industrial enzymes.

Core expertise

What they specialise in

Plant epigenetics and gene regulationprimary
12 projects

Multiple ERC and MSCA projects on DNA methylation (MaintainMeth, SexMeth), RNA structure (RivRNAStructureDecay), non-coding RNA (UNRAVEL, WISDOM), and chromatin regulation (AMBITION, PEP-NET).

Wheat genetics and cereal crop improvementprimary
6 projects

Projects spanning wheat meiosis (Crossover control), cereal disease resistance (CEREALPATH, DeMMYR, RUSTWATCH), and polyploid genome biology (HOTSPOT, EVO-MEIO).

Genome editing and new breeding techniquesemerging
3 projects

Recent projects Newcotiana and others apply CRISPR/Cas9, cisgenesis, and agroinfiltration for crop trait modification, reflecting a clear shift in the later H2020 period.

Plant-pathogen interactions and immunityprimary
5 projects

Significant body of work including ImmunityByPairDesign, INTERCELLAR (symplastic immunity), BLASTOFF (blast fungi resistance), and HOPESEE.

Natural product biosynthesis and molecular farmingsecondary
5 projects

Projects on triterpenoid discovery (TRIGEM), medicinal plant chemistry (MedPlant), alkaloid production (MIAMi), and plant-based pharmaceutical manufacturing (Pharma-Factory, Newcotiana).

Intercellular RNA signaling and transportsecondary
3 projects

PLAMORF studies mobile RNAs, INTERCELLAR examines symplastic exchange, and ComPreValRther predicts RNA thermometers — together forming a distinctive niche in plant cell communication.

Evolution & trajectory

How they've shifted over time

Early focus
Arabidopsis epigenetics and enzyme discovery
Recent focus
Wheat genome editing and DNA methylation

In the early H2020 period (2015-2017), JIC's portfolio was broad — spanning enzyme discovery in medicinal plants (CHLOROIRIDOIDS), tomato breeding for climate resilience (TomGEM), and foundational epigenetics work on Arabidopsis. From 2018 onward, there is a clear convergence toward wheat and polyploid genome biology, genome editing (CRISPR/Cas9), and DNA methylation mechanisms. The later projects also show increased interest in using plants as bioproduction platforms (molecular farming) and in mobile RNA signaling — topics that were absent from the early portfolio.

JIC is moving from fundamental Arabidopsis research toward applied wheat genomics and genome editing tools, positioning itself as a go-to partner for next-generation crop breeding projects.

Collaboration profile

How they like to work

Role: consortium_leaderReach: European26 countries collaborated

JIC leads projects more often than it joins them — 22 of 38 projects as coordinator (58%), which is unusually high and reflects strong PI-driven grant capture, especially through individual ERC and MSCA fellowships. Their participant roles tend to be in larger multi-partner consortia (CEREALPATH, TomGEM, RUSTWATCH), while their coordinated projects are typically smaller, PI-led grants. With 124 unique partners across 26 countries, they operate as a broad European hub rather than relying on a fixed set of repeat collaborators.

JIC has collaborated with 124 distinct partners across 26 countries, indicating deep pan-European reach. As a UK-based institute, their network spans the EU despite Brexit, with particularly strong connections through multi-partner crop science and plant biology consortia.

Why partner with them

What sets them apart

JIC combines world-class fundamental plant science (epigenetics, RNA biology, natural product chemistry) with direct relevance to crop improvement — a rare pairing that lets them move discoveries from Arabidopsis to wheat faster than most competitors. Their high rate of ERC and MSCA grants signals that individual researchers there are among Europe's most competitive in plant sciences. For consortium builders, JIC brings both deep mechanistic expertise and practical crop breeding connections, making them valuable as a scientific anchor partner in food security and agri-biotech projects.

Notable projects

Highlights from their portfolio

  • INTERCELLAR
    Largest coordinated grant (EUR 2.16M ERC Consolidator), investigating a distinctive research niche — how pathogens exploit intercellular communication channels in plants.
  • MaintainMeth
    Highest single-project funding (EUR 2.41M) as participant, reflecting JIC's contribution to a major ERC program on quantitative DNA methylation analysis.
  • Newcotiana
    Represents JIC's applied genome editing work — using CRISPR/Cas9 and new breeding techniques to develop Nicotiana as a molecular farming platform for pharmaceuticals.
Cross-sector capabilities
Health & pharmaceuticals (molecular farming, plant-derived vaccines and diagnostics)Biotechnology (genome editing tools, CRISPR applications, biosynthesis)Environment & biodiversity (crop resilience, disease resistance, climate adaptation)Industrial bioprocessing (enzyme discovery, natural product chemistry)
Analysis note: Strong dataset with 38 projects and clear keyword evolution. JIC's high coordinator rate (58%) is driven by individual ERC/MSCA fellowships rather than large collaborative actions, which slightly inflates the 'consortium leader' label — in practice, many coordinated projects are single-PI grants. Eight projects beyond the displayed 30 were not analyzed but are unlikely to change the overall profile significantly.